JAK inhibitors

Vitiligo: Practical Management Backed by Evolving Science
vitiligo managementIn an insightful session at the ODAC Dermatology Conference, leading vitiligo expert Dr. Iltefat Hamzavi—clinical associate professor of dermatology at Wayne State University and senior staff dermatologist at Henry Ford Hospital—shared key strategies for tackling this complex condition. Here is a practical summary of his top clinical pearls, from disease stabilization to emerging systemic trea …
vitiligo management
Alopecia: Medical Treatment Pearls
Medical treatment of alopeciaNew treatments are giving alopecia patients hope, according to ODAC Medical Dermatology Advisor Jennifer Soung, MD, FAAD. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Soung, who shares her pearls for the medical treatment of alopecia. Watch as Dr. Soung outlines the AST tool to determine alopecia severity. Hear a summary of approved JAK inhibitors for al …
Medical treatment of alopecia
Common, Yet Overlooked Skin Conditions
Overlooked Skin ConditionsDermatologists treat more than 3,000 conditions, but not all of them receive equal attention. In this Next Steps in Derm video interview, in partnership with the ODAC Dermatology Conference, ODAC Conference Co-Chair Adam Friedman, MD, FAAD, addresses common, yet overlooked skin conditions, most of which do not have FDA-approved therapies. Watch and learn tips for the creative management of lichen …
Overlooked Skin Conditions
Abrocitinib Therapeutic Cheat Sheet
Abrocitinib Therapeutic Cheat SheetAbrocitinib is an oral, once-daily selective Janus kinase 1 (JAK1) inhibitor approved for moderate-to-severe atopic dermatitis. It can provide rapid improvement in pruritus and skin disease and is a useful treatment option for many patients. As an oral medication, it may also be preferred by patients who want to avoid injections. When prescribing abrocitinib, it is important to discuss laboratory …
Abrocitinib Therapeutic Cheat Sheet
Scarring Alopecias: Pathophysiology, Diagnostic Clues, and Medical Treatment Options
scarring alopecias in skin of colorScarring alopecias in skin of color are increasingly recognized and remain a major cause of irreversible hair loss. During the 2025 Skin of Color Update in New York City, Susan C. Taylor, MD, presented an updated clinical approach to identifying and managing lichen planopilaris (LPP), frontal fibrosing alopecia (FFA), and central centrifugal cicatricial alopecia (CCCA) with a focus on early detect …
scarring alopecias in skin of color